David R. Gandara
Member of Scientific & Medical Advisory BoardDr. David R. Gandara, M.D., served as Member of Scientific Advisory Board at Shanghai Henlius Biotech, Inc.(Formerly known as Shanghai Henlius Biotech Co. Ltd.) since July 2023 until 2025. Dr. Gandara served as a Member of Advisory Board at Xilis, Inc. Dr. Gandara serves as Scientific and Strategic Advisory Board at Adagene Inc. January 2022. He joined Adagene Inc. in January 2022. He is the Member of Scientific Advisory Board at Ocean Genomics, Inc. He serves as Member of Scientific & Medical Advisory Board at Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation). Dr. Gandara serves as Member of Scientific Advisory Board at Oncohost Ltd. since November 2021. He was appointed Chief Medical Officer (CMO) of the International Society for Liquid Biopsy. Dr. Gandara has received numerous awards, authored over 450 publications and presented his work at meetings nationally and internationally. He is a co-leader at Lung MAP, a precision medicine umbrella clinical trial for the development of biomarker-driven strategies for new therapies in lung cancer. Dr. Gandara serves as an Associate Director of Clinical Research and has been Director of Thoracic Oncology at the University of California, Davis Cancer Center since 1994. Dr. Gandara has been a professor of medicine at the University of California, Davis School of Medicine. since 1994. He served as Independent Director of Response Genetics, Inc. from April 30, 2008 to January 2010. He is a diplomat of the American Board of Internal Medicine specializing in Medical Oncology. He also serves on the Board of Directors for the International Association for the Study of Lung Cancer (IASLC) and is a prior Board Member and Secretary-Treasurer of the American Society for Clinical Oncology (ASCO). He completed his clinical training as a resident at Madigan Army Medical Center and as a Fellow in hematology and oncology at Letterman Army Medical Center. Dr. Gandara received his M.D. from the University of Texas Medical Branch and holds a B.A. from the University of Texas.
Positions
- Company NameInsight Molecular Diagnostics Inc.Stock CodeIMDXPositionMember of Scientific & Medical Advisory BoardColleagues
- JRJoshua RiggsPresident, CEO & Director
- AAAndrew ArnoIndependent Chairman
- ASAndrea Susan JamesChief Financial Officer
- JLJames LiuVP of Accounting, Treasurer, Controller & Principal Accounting Officer
- YCYuh-Min ChiangChief Technology Officer
- ESEkkehard SchutzChief Science Officer
- AJAndrew J. LastIndependent Director
- LELouis E. SilvermanIndependent Director
